Evaluating radiotherapy treatments for head and neck cancer
Assessment of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Head and Neck Neoplasms Treated With Radiotherapy at the IRCCS Azienda Ospedaliero-Universitaria di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06773039
This study is trying to see how well different radiotherapy treatments work for people with head and neck cancer and what side effects they might cause.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna (other) |
| Drugs / interventions | radiation |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06773039 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect data on the effectiveness and toxicity of radiotherapy treatments for patients with head and neck neoplasms. It will systematically gather information regarding tumor responses, treatment dosages, techniques used, and the psychological impact of these therapies. By analyzing a large sample of patients treated since January 1, 2000, the study seeks to identify correlations between disease characteristics and radiation-induced toxicities, ultimately aiming for personalized treatment approaches in the future.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a new or previous diagnosis of malignant head and neck neoplasms treated at the Radiotherapy Unit of the S. Orsola Polyclinic.
Not a fit: Patients who do not have a malignant neoplasm of the head and neck or those who are under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prediction and prevention of radiation-induced toxicities in patients undergoing treatment for head and neck cancer.
How similar studies have performed: While this study focuses on a specific observational approach, similar studies have shown success in evaluating treatment outcomes and toxicities in cancer therapies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients of both sexes, aged ≥ 18 years, with new or previous diagnosis of malignant neoplasm of the head and neck, from January 1, 2000, treated at the Radiotherapy Unit of the S. Orsola Polyclinic * Obtaining informed consent Exclusion Criteria: * None
Where this trial is running
Bologna
- IRCCS Azienda Ospedaliero - Universitaria di Bologna — Bologna, Italy (RECRUITING)
Study contacts
- Principal investigator: Alessio Giuseppe Morganti, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Alessio Giuseppe Morganti, MD
- Email: alessio.morganti2@unibo.it
- Phone: +39 0516363136
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Head and Neck Cancer